These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12929281)

  • 1. Avinza (morphine sulfate extended-release capsules).
    King CR; Khabazian A
    Clin J Oncol Nurs; 2003; 7(4):458-60, 478. PubMed ID: 12929281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy comparison between morphine sulfate controlled-released tablet and morphine hydrochloride sustained-released tablet in treating cancer pain].
    Yao WX; Zhou H; Wang LY; Wei Y; Liu XY
    Ai Zheng; 2007 Dec; 26(12):1357-9. PubMed ID: 18076801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.
    Ross EL; Hahn K
    Int J Clin Pract; 2008 Mar; 62(3):471-9. PubMed ID: 18261077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing.
    Smith HS
    Expert Opin Pharmacother; 2011 May; 12(7):1111-25. PubMed ID: 21470065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
    Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
    Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain.
    Webster LR; Brewer R; Wang C; Sekora D; Johnson FK; Morris D; Stauffer J
    J Pain Symptom Manage; 2010 Nov; 40(5):734-46. PubMed ID: 21075272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine sulfate extended-release capsules for the treatment of chronic, moderate-to-severe pain.
    Nicholson B
    Expert Opin Pharmacother; 2008 Jun; 9(9):1585-94. PubMed ID: 18518787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 10. Extended-release epidural morphine (DepoDur).
    Pasero C; McCaffery M
    J Perianesth Nurs; 2005 Oct; 20(5):345-50. PubMed ID: 16246812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pain and opioids: reasons for an injustice].
    Baños JE
    Med Clin (Barc); 1997 Sep; 109(8):294-6. PubMed ID: 9379751
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
    Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
    J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer pain management.
    Portenoy RK
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):30-2. PubMed ID: 16166965
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphine as the first drug for the treatment of cancer pain.
    Nunes BC; Garcia JB; Sakata RK
    J Palliat Med; 2012 Sep; 15(9):963-4. PubMed ID: 22946573
    [No Abstract]   [Full Text] [Related]  

  • 15. PRODUCT: Embeda 20mg/0.8mg.
    Physician Assistant's Prescribing Reference
    JAAPA; 2009 Nov; 22(11):12. PubMed ID: 19999169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extended release oxycodone. An oral opioid analgesic for cancer patients with chronic pain].
    Taeron C
    Rev Infirm; 2002 Nov; (85):47-9. PubMed ID: 12510533
    [No Abstract]   [Full Text] [Related]  

  • 17. [Do not be afraid to administer analgesics! Patients with cancer feel pain].
    Anderes R; Stoll H
    Krankenpfl Soins Infirm; 1989 May; 82(5):81-4. PubMed ID: 2568514
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.
    Katz N; Hale M; Morris D; Stauffer J
    Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules.
    Weil AJ; Nicholson B; Sasaki J
    J Opioid Manag; 2009; 5(1):39-45. PubMed ID: 19344047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse suggests that all pain drugs be converted to oral morphine.
    Pace M
    Clin J Oncol Nurs; 2008 Jun; 12(3):394-5. PubMed ID: 18567130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.